We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Tool Provides Reliable Method for Identifying Pathogens

By LabMedica International staff writers
Posted on 15 Dec 2023
Print article
Image: The new method identifies bacteria easily, cheaply and more precisely than before (Photo courtesy of NTNU)
Image: The new method identifies bacteria easily, cheaply and more precisely than before (Photo courtesy of NTNU)

The overuse of antibiotics globally has led to an increase in antibiotic-resistant bacteria, making the treatment of bacterial diseases increasingly challenging. Antibiotics are a crucial tool in combating these infections, and reducing their usage is essential. To aid in this effort, researchers have devised a new method for identifying bacteria that is simpler, less expensive, and more accurate than previous techniques. This advancement could play a significant role in reducing antibiotic use.

The new method developed by an international research group led by the Norwegian University of Science and Technology (NTNU, Trondheim, Norway) is faster because it eliminates the need for 'gene amplification'. This traditional step, which involves creating multiple copies of genetic material for easier analysis, is no longer necessary. The innovative method focuses on detecting short DNA sequences of bacteria. It achieves this by observing the binding of these sequences to various DNA variants are grafted onto colloids – particles suspended in a liquid.

This approach allows for rapid bacterial identification by analyzing how different bacteria bind to these colloids, causing the, to clump together. The advantage here is the reduced need for analyzing large volumes of genetic material and the ability to bypass the gene copying process. This results in time and cost savings. While this method is still in the early stages of development, it holds significant potential, especially in a context where antibiotic resistance is a growing concern. More work is needed to bring this method into mainstream usage

“We have developed a simple tool that can identify all of the genetic material in bacteria,” said Professor Erika Eiser at NTNU’s Department of Physics. “This allows us to find out more quickly what kind of bacteria a sick person or animal is affected by, or what kind of bacteria are found in food or the environment. We can then also decide whether it is necessary to use antibiotics against the bacterium, and if so what kind, so we don’t have to use as much medication.”

Related Links:
NTNU 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The proposed self-powered, millifluidic lab-on-a-chip device to determine blood conductivity (Photo courtesy of Advanced Materials/DOI: 10.1002/adma.202403568)

First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring

Metabolic disorders such as diabetes and osteoporosis are rapidly increasing globally, especially in developing countries. Diagnosing these conditions generally requires blood tests; however, in remote... Read more

Hematology

view channel
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more

Pathology

view channel
Image illustrating four prognostic scenarios that may be found in liver biopsies when pancreatic cancer is diagnosed before metastasis (Photo courtesy of Vanessa Dudley/Weill Cornell Medicine)

Liver Biopsy Reveals Early Signs of Rapid Metastasis in Pancreatic Cancer Patients

Only 10% of individuals diagnosed with pancreatic cancer will live beyond two years post-diagnosis. The ability to predict the timing and location of metastases could dramatically transform the treatment... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.